Loading

Review Article Open Access
Volume 5 | Issue 3 | DOI: https://doi.org/10.33696/Neurol.5.094

The Role and Mechanism of Autoantibodies in Dysimmunity Related Neurological Diseases

  • 1Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Department of Immunology and Pathogen Biology, School of Basic Medical Sciences, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 311121, China
  • 2Medical College of Lishui University, Lishui, 323000, China
  • 3The Fourth People' s Hospital of Lin’an District, Hangzhou, 311300, China
  • #These authors contributed equally to this work
+ Affiliations - Affiliations

Corresponding Author

*Corresponding author: Jing Wu, wu.jing@hznu.edu.cn; Kaibo Zhang, kaibo1979@163.com

Received Date: March 02, 2024

Accepted Date: April 16, 2024

Abstract

Autoantibodies are antibodies produced by B cells capable of attacking their own tissues or organs after loss of immune tolerance. A large body of literature shows that autoantibodies play an important role in neurological diseases associated with immune abnormalities. Nowadays, neurological disorders are an important cause of disability and death in populations around the world, so it is important to study the role and mechanisms of autoantibodies in neurological disorders associated with immune abnormalities. The blood-brain barrier is biologically important for maintaining the normal physiological state of the central nervous system, and we have previously found that monoclonal autoantibodies of SLE origin can inhibit the expression of tight junction proteins in the blood-brain barrier. Our findings provide clues for the study of the role of autoantibodies in neurological disorders and greatly attract us to conduct a more in-depth and systematic review and synthesis. In this paper, we summarize the functions of autoantibodies in autoimmune and non-autoimmune diseases and focus on the roles and mechanisms of autoantibodies in immune-associated neurological disorders by taking central and peripheral neurological diseases as the entry points, which can provide new molecular targets and new theoretical basis for the specific diagnosis and targeted therapy of neurological diseases.

Keywords

Autoantibodies, Dysimmunity related neurological diseases, Diagnosis, Therapy, Pathogenesis

Author Information X